VRDN CIK: 1590750

Viridian Therapeutics, Inc.\DE

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.43
FY23:
0.49
FY24:
0.74
FY25:
0.89
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.44
FY23:
0.49
FY24:
0.74
FY25:
0.90

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.03
FY23:
0.03
FY24:
0.05
FY25:
0.07
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.01
FY23:
0.02
FY24:
0.02
FY25:
0.11
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.40
FY23:
0.44
FY24:
0.67
FY25:
0.72
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.44
FY23:
0.49
FY24:
0.74
FY25:
0.90

All amounts in billions USD Data source:SEC EDGAR